Ńîąóĺú´«Ă˝Ň•îl

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • Ńîąóĺú´«Ă˝Ň•îl Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jul 23 2026 UPDATED 9:29 AM

Full Issue

Trump Admin Plan Would Limit Scholarly Research In Favor Of AI

“America will lead the next generation of medical discovery by harnessing the power of artificial intelligence,” HHS Secretary Robert F. Kennedy Jr. said. Science adviser Michael Kratsios called for science agencies to improve their methods for measuring returns on investments and prioritize physical sciences, chemistry, and biological sciences, with an emphasis on artificial intelligence, among other areas.

President Trump’s science adviser told lawmakers on Wednesday that the Trump administration intended to drastically overhaul the country’s approach to scientific research, including by shifting research funding away from universities toward individual researchers and private companies. At a House hearing, Michael Kratsios echoed points he laid out in a report released Tuesday, titled “Science: A New Golden Age.” He said the administration would prioritize artificial intelligence, robotics and nuclear energy while reducing the government’s focus on what he called “life sciences.” (Flavelle and Stolberg, 7/22)

More than a quarter of physician-industry interactions for research funding also involved the doctor receiving general payments from that same sponsor, an analysis of CMS data showed. In an analysis of nearly 60,000 physician-industry interactions, those payments peaked around the time the research began, Alon Bergman, PhD, of the University of Pennsylvania, and colleagues reported in JAMA Network Open. (Clark, 7/22)

Texas spent billions recruiting scientists from around the world to turn the state into a cancer-research powerhouse. Now, nearly six months after Gov. Greg Abbott restricted public institutions’ use of the H-1B visa program, cancer advocates and immigration attorneys warn the policy could undercut that strategy. (Priest and Ngo, 7/22)

In other news about the Trump administration —

A slate of experimental peptide therapies are under scrutiny today in what marks the beginning of a two-day meeting to help determine whether the compounds will become available from specialized pharmacies. The panel of advisers to the Food and Drug Administration is considering the evidence for seven compounds including some of the most sought-after: TB-500, BPC-157 and MOTs-C. (Stone, 7/23)

The Trump administration will appeal a Georgia court ruling that triggered a broad recalculation of insurers' Medicare Advantage star rating scores for 2026. In court documents filed Tuesday, federal agencies said they would appeal the ruling to the Eleventh Circuit Court of Appeals. In late May, a judge in Georgia's Southern District Court came down in favor of Clover Health, tossing 20 measures that the Centers for Medicare & Medicaid Services used to calculate its scores. (Minemyer, 7/22)

Ńîąóĺú´«Ă˝Ň•îl Health News: Public Health Improvements Stall Amid Trump’s DEI Crackdown 

As Earl Williams drove through a historic Black neighborhood known as Dewey City in his hometown, he hardly recognized what he saw. Homes that once belonged to friends, family, and neighbors had siding covered in mold. Some were boarded up. Others had holes in their roofs. (Lumpkins, 7/23)

On the dismantling of USAID —

She paces the side of the darkened highway in central Nepal, just enough light from the trucks roaring past to illuminate her painted face to the men rolling in on rickshaws and motorbikes. She knows that every stranger who pays for her body could end her life. But she also knows their money is the only thing preventing her death. This spot, littered in condom wrappers and fringed by jungle, is familiar to her. Rubi Lama once came here not as a sex worker, but as an aid worker who helped sex workers. (Gelineau, 7/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, July 23
  • Wednesday, July 22
  • Tuesday, July 21
  • Monday, July 20
  • Friday, July 17
  • Thursday, July 16
More Morning Briefings
RSS Feeds
  • Ńîąóĺú´«Ă˝Ň•îl
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF